Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Sleep Disordered Breathing and Cerebral Small Vessel Disease in the Cognitively Impaired: A Useful Therapeutic Target?
EF 2021-22
Résumé
Sleep disordered breathing is common in aging and contributes negatively to both cardiovascular and brain health outcomes. A common form of sleep disordered breathing, obstructive sleep apnea (OSA), is characterized by repetitive upper airway collapse during sleep causing reduced airflow, which results in reduced blood oxygen concentration. Patients may experience excessive daytime sleepiness, which can be debilitating and impair daytime functioning. OSA has been linked to cerebral small vessel disease (SVD), which is visible on magnetic resonance imaging (MRI) brain scans, as well as declining cognitive function. Additionally, a common treatment for OSA, continuous positive airway pressure (CPAP), effectively reduces the symptoms of OSA and slows cognitive impairment. However, the majority of prior work has explored individuals with normal cognitive function, and almost none of the past research has focused on patients with varying degrees of cognitive impairment.The research proposed here aims to determine if OSA is linked to SVD in cognitively impaired people. Additionally, it aims to discover if SVD impacts the effectiveness of CPAP on cognitive function in the cognitively impaired. The subjects for this study will be patients diagnosed with cognitive impairment at Sunnybrook Health Sciences Centre. All subjects will undergo sleep testing, an MRI scan, and cognitive testing. MRI scans will be processed using an imaging pipeline to determine the severity of SVD in patients. Currently, there are no effective methods for stopping or reversing cognitive impairment in patients with dementia and Alzheimers disease. The research proposed here may reveal whether OSA is a therapeutic target for preserving or improving cognitive function in these patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466600
Name
Settimi Matthew
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sleep Disordered Breathing and Cerebral Small Vessel Disease in the Cognitively Impaired: A Useful Therapeutic Target?
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cerebral Small Vessel Disease; Cognitive Impairment; Continuous Positive Airway Pressure (Cpap); Magnetic Resonance Imaging; Polysomnography; Sleep Apnea; Sleep Disordered Breathing
Abstract
Sleep disordered breathing is common in aging and contributes negatively to both cardiovascular and brain health outcomes. A common form of sleep disordered breathing, obstructive sleep apnea (OSA), is characterized by repetitive upper airway collapse during sleep causing reduced airflow, which results in reduced blood oxygen concentration. Patients may experience excessive daytime sleepiness, which can be debilitating and impair daytime functioning. OSA has been linked to cerebral small vessel disease (SVD), which is visible on magnetic resonance imaging (MRI) brain scans, as well as declining cognitive function. Additionally, a common treatment for OSA, continuous positive airway pressure (CPAP), effectively reduces the symptoms of OSA and slows cognitive impairment. However, the majority of prior work has explored individuals with normal cognitive function, and almost none of the past research has focused on patients with varying degrees of cognitive impairment.The research proposed here aims to determine if OSA is linked to SVD in cognitively impaired people. Additionally, it aims to discover if SVD impacts the effectiveness of CPAP on cognitive function in the cognitively impaired. The subjects for this study will be patients diagnosed with cognitive impairment at Sunnybrook Health Sciences Centre. All subjects will undergo sleep testing, an MRI scan, and cognitive testing. MRI scans will be processed using an imaging pipeline to determine the severity of SVD in patients. Currently, there are no effective methods for stopping or reversing cognitive impairment in patients with dementia and Alzheimers disease. The research proposed here may reveal whether OSA is a therapeutic target for preserving or improving cognitive function in these patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Settimi, Matthew
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~